Women with multiple implantation failures and recurrent pregnancy losses have increased peripheral blood T cell activation

American Journal of Reproductive Immunology

Volumn 63, Issue 5, 2010, Pages 370-378

  Yang, Kwang Moon ^a,b   Ntrivalas, Evangelos ^a   Cho, Hye Jin ^a   Kim, Na Young ^a   Beaman, Kenneth ^a   Gilman Sachs, Alice ^a   Kwak Kim, Joanne ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b Kwandong University College of Medicine   (South Korea)

Author keywords

CD154; CD69; Implantation failures; IVF ET; Recurrent pregnancy losses; T cell activation

Indexed keywords

CD40 LIGAND; CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE COUNT; PERIPHERAL LYMPHOCYTE; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT ABORTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TREATMENT FAILURE;

ABORTION, HABITUAL; ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; EMBRYO IMPLANTATION; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953064102     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00811.x     Document Type: Article

References (44)

1. Bates MD, Quenby S, Takakuwa K, Johnson PM, Vince GS. Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss? Hum Reprod 2002, 17:2439-2444.
2. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gilman-Sachs A. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003, 18:767-773.
3. Wang ZC, Hill JA, Yunis EJ, Xiao L, Anderson DJ. Maternal CD46H*2 and IL1B-511*1 homozygosity in T helper 1-type immunity to trophoblast antigens in recurrent pregnancy loss. Hum Reprod 2006, 21:818-822.
4. Ahmad SM, Haskell MJ, Raqib R, Stephensen CB. Markers of innate immune function are associated with Vitamin A stores in men. J Nutr 2009, 139:377-385.
5. Bouguermouh S, Van VQ, Martel J, Gautier P, Rubio M, Sarfati M. CD47 expression on T cell is a self-control negative regulator of type 1 immune response. J Immunol 2008, 180:8073-8082.
6. Banchereau J, Bazan F, Blanchard D, Brière F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S. The CD40 antigen and its ligand. Annu Rev Immunol 1994, 12:881-922.
7. Leitenberg D, Bottomly K. Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Semin Immunol 1999, 11:283-292.
8. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000, 290:92-97.
9. Noelle RJ. CD40 and its ligand in host defense. Immunity 1996, 4:415-419.
10. Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J, Gately M, Delespesse G. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995, 25:1125-1128.
11. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:547-549.
12. Martin M, Metzger DJ, Michalek SM, Connell TD, Russell MW. Distinct cytokine regulation by cholera toxin and type II heat-labile toxins involves differential regulation of CD40 ligand on CD4(+) T cells. Infect Immun 2001, 69:4486-4492.
13. Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells 1994, 12:456-465.
14. Ziegler SF, Levin SD, Johnson L, Copeland NG, Gilbert DJ, Jenkins NA, Baker E, Sutherland GR, Feldhaus AL, Ramsdell F. The mouse CD69 gene. Structure, expression, and mapping to the NK gene complex. J Immunol 1994, 152:1228-1236.
15. Santis AG, Campanero MR, Alonso JL, Tugores A, Alonso MA, Yagüe E, Pivel JP, Sánchez-Madrid F. Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur J Immunol 1992, 22:1253-1259.
16. Testi R, Phillips JH, Lanier LL. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C. J Immunol 1989, 142:1854-1860.
17. Cebrian M, Yague E, Rincon M, Lopez-Botet M, de Landazuri MO, Sanchez-Madrid F. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med 1988, 168:1621-1637.
18. Nakamura S, Sung SS, Bjorndahl JM, Fu SM. Human T cell activation. IV. T cell activation and proliferation via the early activation antigen EA 1. J Exp Med 1989, 169:677-689.
19. Santamaria M, Marubayashi M, Arizon JM, Montero A, Concha M, Valles F, Lopez A, Lopez F, Peña J. The activation antigen CD69 is selectively expressed on CD8+ endomyocardium infiltrating T lymphocytes in human rejecting heart allografts. Hum Immunol 1992, 33:1-4.
20. Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 2002, 48:77-86.
21. Flavell RA, Li B, Dong C, Lu HT, Yang DD, Enslen H, Tournier C, Whitmarsh A, Wysk M, Conze D, Rincon M, Davis RJ. Molecular basis of T-cell differentiation. Cold Spring Harb Symp Quant Biol 1999, 64:563-571.
22. Jenkins SJ, Perona-Wright G, MacDonald AS. Full development of Th2 immunity requires both innate and adaptive sources of CD154. J Immunol 2008, 180:8083-8092.
23. Avice MN, Demeure CE, Delespesse G, Rubio M, Armant M, Sarfati M. IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligation. J Immunol 1998, 161:3408-3415.
24. Hirohata S. Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligand. Clin Exp Immunol 1999, 115:78-85.
25. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 1996, 14:591-617.
26. Shibuya H, Nagai T, Ishii A, Yamamoto K, Hirohata S. Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-alpha. Clin Exp Immunol 2003, 132:216-224.
27. Hoshino T, Yagita H, Ortaldo JR, Wiltrout RH, Young HA. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur J Immunol 2000, 30:1998-2006.
28. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 1998, 10:259-264.
29. Ledee-Bataille N, Bonnet-Chea K, Hosny G, Dubanchet S, Frydman R, Chaouat G. Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure. Fertil Steril 2005, 83:598-605.
30. Darmochwal-Kolarz D, Kolarz B, Surdacka A, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. The expression and concentration of CD40 ligand in normal pregnancy and pre-eclampsia. J Reprod Immunol 2009, 79:215-219.
31. Wilczynski JR. Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia - the same basic mechanism? Hum Immunol 2006, 67:492-511.
32. Ziegler SF, Ramsdell F, Hjerrild KA, Armitage RJ, Grabstein KH, Hennen KB, Farrah T, Fanslow WC, Shevach EM, Alderson MR. Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur J Immunol 1993, 23:1643-1648.
33. Lindsey WB, Lowdell MW, Marti GE, Abbasi F, Zenger V, King KM, Lamb LS. CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery. Cytotherapy 2007, 9:123-132.
34. Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, Chung-Bang H, Ng SC, Beaman KD, Mantouvalos HP, Beer AE. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001, 16:855-861.
35. Coulam CB, Roussev RG. Correlation of NK cell activation and inhibition markers with NK cytotoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer. J Assist Reprod Genet 2003, 20:58-62.
36. Maruyama T, Makino T, Sugi T, Matsubayashi H, Ozawa N, Nozawa S. Flow-cytometric analysis of immune cell populations in human decidua from various types of first-trimester pregnancy. Hum Immunol 1992, 34:212-218.
37. Saito S, Nishikawa K, Morii T, Narita N, Enomoto M, Ichijo M. Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2R alpha) and IL-2R beta on T cells of human decidua at an early stage of pregnancy. Immunology 1992, 75:710-712.
38. Fanslow WC, Clifford KN, Seaman M, Alderson MR, Spriggs MK, Armitage RJ, Ramsdell F. Recombinant CD40 ligand exerts potent biologic effects on T cells. J Immunol 1994, 152:4262-4269.
39. Shimojima Y, Matsuda M, Ishii W, Gono T, Ikeda S. Analysis of peripheral blood lymphocytes using flow cytometry in polymyalgia rheumatica, RS3PE and early rheumatoid arthritis. Clin Exp Rheumatol 2008, 26:1079-1082.
40. Young HA, Hardy KJ. Interferon-gamma: producer cells, activation stimuli, and molecular genetic regulation. Pharmacol Ther 1999, 45:137-151.
41. Berner B, Akca D, Jung T, Muller GA, Reuss-Borst MA. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 2000, 27:1128-1135.
42. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
43. Cunard R, Eto Y, Muljadi JT, Glass CK, Kelly CJ, Ricote M. Repression of IFN-gamma expression by peroxisome proliferator-activated receptor. gamma. J Immunol 2004, 172:7530-7536.
44. Ordway D, Higgins DM, Sanchez-Campillo J, Spencer JS, Henao-Tamayo M, Harton M, Orme IM, Gonzalez Juarrero M. XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability. J Leukoc Biol 2007, 82:1221-1229.